AR211153A1 - Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima. - Google Patents

Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima.

Info

Publication number
AR211153A1
AR211153A1 AR265801A AR26580176A AR211153A1 AR 211153 A1 AR211153 A1 AR 211153A1 AR 265801 A AR265801 A AR 265801A AR 26580176 A AR26580176 A AR 26580176A AR 211153 A1 AR211153 A1 AR 211153A1
Authority
AR
Argentina
Prior art keywords
triflourmethylphenylketoxima
aminocetil
subtituted
eters
alkyl
Prior art date
Application number
AR265801A
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of AR211153A1 publication Critical patent/AR211153A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
AR265801A 1975-03-20 1976-12-10 Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima. AR211153A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
AR211153A1 true AR211153A1 (es) 1977-10-31

Family

ID=19823424

Family Applications (2)

Application Number Title Priority Date Filing Date
AR262650A AR211011A1 (es) 1975-03-20 1976-03-22 Metodo para producir compuestos de eteres de o-(2-aminoetil)-n-alquil (c3-c4)-sustuitido-ptrifluormetilfenilcetoxin
AR265801A AR211153A1 (es) 1975-03-20 1976-12-10 Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR262650A AR211011A1 (es) 1975-03-20 1976-03-22 Metodo para producir compuestos de eteres de o-(2-aminoetil)-n-alquil (c3-c4)-sustuitido-ptrifluormetilfenilcetoxin

Country Status (27)

Country Link
US (1) US4085225A (es)
JP (1) JPS6026776B2 (es)
AR (2) AR211011A1 (es)
AT (1) AT340895B (es)
AU (1) AU505358B2 (es)
BE (1) BE839744A (es)
CA (1) CA1076142A (es)
CH (4) CH626057A5 (es)
DD (1) DD128332A5 (es)
DE (1) DE2610886A1 (es)
DK (1) DK144942C (es)
ES (1) ES446192A1 (es)
FI (1) FI61875C (es)
FR (1) FR2304336A1 (es)
GB (1) GB1535226A (es)
GR (1) GR60052B (es)
HU (1) HU171030B (es)
IE (1) IE43768B1 (es)
IL (1) IL49238A (es)
IT (1) IT1063064B (es)
MX (1) MX9203723A (es)
NL (1) NL7503310A (es)
PL (3) PL100614B1 (es)
SE (1) SE410312B (es)
SU (3) SU635867A3 (es)
YU (1) YU39345B (es)
ZA (1) ZA761434B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
DK0759299T3 (da) * 1995-08-16 2000-08-07 Lilly Co Eli Potensering af serotoninrespons
IN182588B (es) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (es) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
WO2001080845A2 (en) * 2000-04-24 2001-11-01 Aryx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
MXPA04003358A (es) * 2001-10-12 2004-07-08 Serenix Pharmaceuticals Llc Antagonistas de vasopresina v1a de ?-lactamilo.
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
WO2005025675A1 (en) 2003-09-12 2005-03-24 Pfizer Limited Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
WO2005051919A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
AU2004305563C1 (en) 2003-12-11 2011-07-07 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
JP2008534504A (ja) 2005-03-22 2008-08-28 アゼヴァン ファーマスーティカルズ，インコーポレイテッド 月経前障害を治療するためのβラクタミルアルカン酸
EP1879875A1 (en) * 2005-04-22 2008-01-23 Wyeth Crystal forms opf {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
AR056979A1 (es) * 2005-04-22 2007-11-07 Wyeth Corp Derivados de dihidrobenzofuranos y usos de los mismos
MX2007013021A (es) * 2005-04-22 2008-01-11 Wyeth Corp Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c.
PE20061298A1 (es) 2005-04-22 2006-12-24 Wyeth Corp Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c
WO2007008758A2 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
SI1910346T1 (sl) * 2005-07-19 2019-08-30 Azevan Pharmaceuticals, Inc. Antagonist beta-laktamil fenilalalina, cisteina in serin vasopresina
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
TW200806300A (en) * 2006-03-24 2008-02-01 Wyeth Corp New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
EP2288345B1 (en) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2491038B1 (en) 2009-10-23 2016-04-06 Janssen Pharmaceutica N.V. Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
WO2012003436A1 (en) 2010-07-01 2012-01-05 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
MX2013010598A (es) 2011-03-17 2014-01-08 Lupin Ltd Composiciones farmaceuticas de liberacion controlada de inhibidor de recaptacion de serotonina selectivo.
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
EP2981518B1 (en) * 2013-04-03 2021-03-03 ZCL Chemicals Ltd. "an improved process for the preparation of fluvoxamine maleate"
DK3104847T3 (da) 2014-02-07 2021-02-01 Tamogatott Kutatocsoportok Irodaja Hidtil ukendt anvendelse af sigma-1-receptoragonistforbindelser
BR112016022575A2 (pt) 2014-03-28 2017-08-15 Azevan Pharmaceuticals Inc Composições e métodos para o tratamento de doenças neurodegenerativas
SI3426251T1 (sl) * 2016-03-10 2022-07-29 Janssen Pharmaceutica Nv Postopki za zdravljenje depresije z antagonisti receptorja oreksina-2
HUE060027T2 (hu) 2016-11-24 2023-01-28 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Készítmények alkalmazása szerv/szövet prezervációjára
JP2020534274A (ja) 2017-09-15 2020-11-26 アゼヴァン ファーマシューティカルズ，インコーポレイテッド 脳損傷を治療するための組成物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
CH629184A5 (de) 1982-04-15
FI61875C (fi) 1982-10-11
SE410312B (sv) 1979-10-08
AR211011A1 (es) 1977-10-14
US4085225A (en) 1978-04-18
DE2610886C2 (es) 1987-09-24
IL49238A0 (en) 1976-05-31
FI61875B (fi) 1982-06-30
PL100614B1 (pl) 1978-10-31
SU635867A3 (ru) 1978-11-30
DK144942C (da) 1982-12-06
CH629477A5 (de) 1982-04-30
ZA761434B (en) 1977-10-26
SE7603341L (sv) 1976-09-21
IT1063064B (it) 1985-02-11
BE839744A (fr) 1976-09-20
YU71476A (en) 1982-10-31
HU171030B (hu) 1977-10-28
ES446192A1 (es) 1977-10-01
DK115976A (da) 1976-09-21
CH626057A5 (es) 1981-10-30
CH629761A5 (de) 1982-05-14
JPS6026776B2 (ja) 1985-06-25
DK144942B (da) 1982-07-12
IE43768B1 (en) 1981-05-20
FI760699A (es) 1976-09-21
AU1214776A (en) 1977-09-22
GB1535226A (en) 1978-12-13
SU620206A3 (ru) 1978-08-15
JPS51125345A (en) 1976-11-01
CA1076142A (en) 1980-04-22
NL7503310A (nl) 1976-09-22
ATA195476A (de) 1977-05-15
MX9203723A (es) 1992-07-01
IL49238A (en) 1978-08-31
YU39345B (en) 1984-10-31
AU505358B2 (en) 1979-11-15
PL101951B1 (pl) 1979-02-28
FR2304336B1 (es) 1979-09-28
SU645559A3 (ru) 1979-01-30
AT340895B (de) 1978-01-10
GR60052B (en) 1978-04-04
DD128332A5 (de) 1977-11-09
FR2304336A1 (fr) 1976-10-15
PL100052B1 (pl) 1978-08-31
IE43768L (en) 1976-09-20
DE2610886A1 (de) 1976-10-07

Similar Documents

Publication Publication Date Title
AR211153A1 (es) Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima.
TR19292A (tr) Olifinlerin polimerizasyonuna mahsus usul
TR19633A (tr) Alfa-olifinleri polimerize etmeye mahsus katalizatoerler
IS988B6 (is) Tannhjólakerfi
SE7611080L (sv) Prismor for fergtelevisionskamera
FR2297633A1 (fr) Po
FR2299514A1 (fr) Po
IT1061117B (it) Procedimento per produrre proteasiacide
SE7505163L (sv) Torneschoke for hagelvapen
FI64257B (fi) Reglerad oskillator
DK268376A (da) Generatorsystem
IT1058646B (it) Generatore di caratteri per la produzione di caratteri
FR2302344A1 (fr) Procede po
FR2298568A1 (fr) Procede po
TR19539A (tr) Buhar jeneratoerue
SE408126B (sv) Berband for blixtlas
TR19184A (tr) Usul
AT341811B (de) Selbstkassierer fur munzen
MX4858E (es) Procedimiento para preparar compuestos de bis-carbamilguanidino-aza-alcano
SE411166B (sv) Berband for blixtlas
SE7609476L (sv) Berkonstruktion for bergtunnlar
FR2300135A1 (fr) Procede po
MX144523A (es) Proceso para producir sulfolaniloxiaiquilheptaalquilciclotetrasiloxanos
IT1069072B (it) Procedimento per produrre triclorometil trifluorometil benzoli
IT1066755B (it) Procedimento per produrre fosfina